首頁 › 癌症（所有類型） › 俄勒岡州 › Portland
Portland, OR 的 癌症（所有類型） 臨床試驗
34 項針對 癌症（所有類型） 的研究正在 Portland（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
招募中2 期
- Providence Portland Medical Center /ID# 277727, Portland
A Study of ASP3082 in Adults With Advanced Solid Tumors
招募中1 期
- Oregon Health and Science University, Portland
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
招募中1 期
- Oregon Health & Science University, Portland
A Study of PHN-012 in Patients With Advanced Solid Tumors
招募中1 期
- PHN-012-001 Site, Portland
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
招募中3 期
- Investigative Site, Portland
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
招募中2/3 期
- OHSU Center for Health & Healing 1, Portland
- Oregon Health and Science University, Portland
- OSHU Center for Health and Healing 2, Portland
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
招募中3 期
- Oregon Health and Science University /ID# 280071, Portland
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
招募中2 期
- Providence Health & Services, Portland
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
招募中2/3 期
- Providence Portland Medical Center, Portland
- Oregon Health and Science University OHSU, Portland
Connect for Cancer Prevention Study (Connect)
招募中觀察性研究歡迎健康志工
- Kaiser Permanente Northwest, Portland
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
招募中1/2 期
- Oregon Health and Science University ( Site 3004), Portland
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
招募中1/2 期
- Oregon Health and Science University /ID# 272282, Portland
A Phase 1/1b Study of IAM1363 in HER2 Cancers
招募中1 期
- Providence Cancer Institute, Portland
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
招募中3 期
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
- Kaiser Permanente Interstate Medical Office Central, Portland
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
招募中1 期
- Providence Portland Medical Center, Portland
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
招募中觀察性研究
- Oregon Health and Science University, Portland
Project: Every Child for Younger Patients With Cancer
招募中觀察性研究
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- Oregon Health and Science University, Portland
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
招募中2 期
- Oregon Health and Science University, Portland
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
招募中3 期
- Legacy Good Samaritan Hospital and Medical Center, Portland
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- 還有 2 項
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
招募中2 期
- OHSU Knight Cancer Institute, Portland
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
招募中2 期
- Northwest Cancer Specialists /ID# 275151, Portland
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
招募中1/2 期
- Providence Cancer Institute Franz Clinic, Portland
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
招募中2 期
- Oregon Health and Science University, Portland
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
招募中1 期
- GSK Investigational Site, Portland
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
招募中
- VA Portland Health Care System, Portland, OR, Portland
Galleri® in the Medicare Population.
招募中歡迎健康志工
- OHSU CEDAR Clinical Trials Portland, Portland
- OHSU CEDAR Clinical Trials Richmond, Portland
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
招募中2 期
- Oregon Health & Science Institute (OHSU), Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
招募中1/2 期
- Providence Neurological Specialties West, Portland
Beat Childhood Cancer Specimen Banking and Data Registry
招募中觀察性研究歡迎健康志工
- Randall Children's Hospital, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
招募中觀察性研究
- Massive Bio SYNERGY-AI site, Portland
Observational Study of Iris Tumors
招募中觀察性研究歡迎健康志工
- Oregon Health & Science University, Portland
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
招募中1/2 期
- Oregon Health & Science University, Portland
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
招募中
- Kaiser Permanente Northwest - Oncology Clinic, Portland
其他城市的 癌症（所有類型） 試驗
- Houston, TX121 項研究
- New York City, NY109 項研究
- Boston, MA85 項研究
- Los Angeles, CA74 項研究
- Nashville, TN65 項研究
- Philadelphia, PA59 項研究
- Washington, DC58 項研究
- Durham, NC58 項研究
- Chicago, IL51 項研究
- Atlanta, GA49 項研究
- Seattle, WA49 項研究
- Arlington, VA48 項研究
Portland 的其他研究
- 非小細胞肺癌46 項研究
- 乳癌33 項研究
- 前列腺癌33 項研究
- 轉移性癌症29 項研究
- 大腸直腸癌28 項研究
- 卵巢癌27 項研究
- 肺癌26 項研究
- 急性髓系白血病25 項研究
- 子宮內膜癌24 項研究
- 頭頸部鱗狀細胞癌19 項研究
- 胰臟癌19 項研究
- 心臟衰竭17 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。